Immunologist
Moderna starts human trials of an mRNA-based flu shot
Moderna gave its mRNA-based seasonal flu vaccine to the first set of volunteers in a clinical trial, the pharmaceutical company announced today. The start of the trial marks the next stage of the company’s work on this type of vaccine technology after the overwhelming success of its COVID-19 vaccine, which was built using the same strategy. Before the COVID-19 pandemic, mRNA vaccines were still largely experimental, even as they were heralded as the future of vaccine development. People who get an mRNA vaccine are injected with tiny snippets of genetic material from the target virus. Their cells use that genetic information to build bits of the virus, which the body’s immune system learns to fight against. The high efficacy of the mRNA COVID-19 vaccines made by Moderna and Pfizer / BioNTec...
Nigerian doctor named one of TIME’s Most Influential People in the world
TIME named Nigerian physician Tunji Funsho to the 2020 TIME100, its annual list of the 100 most influential people in the world. The full list and related tributes are available now at time.com/time100, and Mr Funsho’s TIME100 profile is available here. The list, now in its seventeenth year, recognizes the activism, innovation and achievement of the world’s most influential individuals. Mr Funsho, a cardiologist based in Lagos, Nigeria, is the first Rotary member to receive this honour for the organisation’s work to eradicate polio, having played an essential role in ensuring Africa’s certification as wild polio-free in August of 2020. “I’m honored to be recognized by TIME for my part in ensuring that no child in Africa will ever again be paralyzed by wild polio, a disease that once disabl...
